InVivoMAb recombinant CTLA-4-Ig (hum/hum) BE0099-R025mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMAb recombinant CTLA-4-Ig (hum/hum)

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMAb recombinant CTLA-4-Ig (hum/hum)

The InVivoMAb recombinant CTLA-4-Ig (hum/hum) Antibody from Bio X Cell Monoclonal antibody.

Product Specs
ItemInVivoMAb recombinant CTLA-4-Ig (hum/hum)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0099-R025mg
Quantity25 mg
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
CloneCTLA-4-Ig (hum/hum)
ClonalityMonoclonal
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology
TargetCTLA-4-Ig
TypeFusion Protein

Specifications/Features

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Functional characterization of human T cell hyporesponsiveness induced by CTLA4-IgPloS oneJanuary 1, 2015Rochman Y, Yukawa M, Kartashov AV, Barski A.

(2) Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in micePloS oneJanuary 1, 2013Schroder PM, Khattar M, Deng R, Xie A, Chen W, Stepkowski SM.

(3) Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expressionJournal of immunology (Baltimore, Md. : 1950)February 15, 2012Chen Y, Shen S, Gorentla BK, Gao J, Zhong XP.

(4) Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in miceAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsJuly 1, 2011Raedler H, Vieyra MB, Leisman S, Lakhani P, Kwan W, Yang M, Johnson K, Faas SJ, Tamburini P, Heeger PS.

(5) Dynamic quantification of host Schwann cell migration into peripheral nerve allograftsExperimental neurologyOctober 1, 2010Whitlock EL, Myckatyn TM, Tong AY, Yee A, Yan Y, Magill CK, Johnson PJ, Mackinnon SE.

(6) IL-6 and TNF-alpha synergistically inhibit allograft acceptanceJournal of the American Society of Nephrology : JASNMay 1, 2009Shen H, Goldstein DR.

Be the First to Write a Review!